Mork Capital Management LLC held its stake in MetLife, Inc. (NYSE:MET) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 25,000 shares of the financial services provider’s stock at the end of the second quarter. MetLife makes up approximately 1.2% of Mork Capital Management LLC’s portfolio, making the stock its 17th biggest holding. Mork Capital Management LLC’s holdings in MetLife were worth $1,374,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in MET. Waldron LP lifted its position in MetLife by 5.1% during the first quarter. Waldron LP now owns 6,492 shares of the financial services provider’s stock valued at $342,000 after buying an additional 315 shares in the last quarter. Klingenstein Fields & Co. LLC lifted its position in MetLife by 0.4% during the first quarter. Klingenstein Fields & Co. LLC now owns 391,515 shares of the financial services provider’s stock valued at $20,680,000 after buying an additional 1,696 shares in the last quarter. Commerzbank Aktiengesellschaft FI lifted its position in MetLife by 25.4% during the first quarter. Commerzbank Aktiengesellschaft FI now owns 149,422 shares of the financial services provider’s stock valued at $7,892,000 after buying an additional 30,298 shares in the last quarter. APG Asset Management N.V. lifted its position in MetLife by 53.8% during the first quarter. APG Asset Management N.V. now owns 3,902,274 shares of the financial services provider’s stock valued at $206,118,000 after buying an additional 1,365,018 shares in the last quarter. Finally, ING Groep NV lifted its position in MetLife by 232.3% during the first quarter. ING Groep NV now owns 55,477 shares of the financial services provider’s stock valued at $2,930,000 after buying an additional 38,780 shares in the last quarter. 74.24% of the stock is currently owned by hedge funds and other institutional investors.

MetLife, Inc. (NYSE:MET) opened at 48.54 on Friday. The company has a market cap of $51.59 billion, a price-to-earnings ratio of 571.06 and a beta of 1.44. The stock’s 50 day moving average is $47.80 and its 200 day moving average is $47.29. MetLife, Inc. has a 52-week low of $38.17 and a 52-week high of $51.77.

MetLife (NYSE:MET) last released its quarterly earnings data on Wednesday, August 2nd. The financial services provider reported $1.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.28 by $0.02. MetLife had a return on equity of 8.51% and a net margin of 0.30%. The firm had revenue of $17.39 billion during the quarter, compared to analyst estimates of $17.11 billion. During the same period in the prior year, the company posted $0.83 earnings per share. The business’s revenue for the quarter was up 2.5% compared to the same quarter last year. On average, analysts predict that MetLife, Inc. will post $4.78 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 13th. Shareholders of record on Monday, August 7th were paid a dividend of $0.40 per share. The ex-dividend date of this dividend was Thursday, August 3rd. This represents a $1.60 annualized dividend and a yield of 3.30%. MetLife’s dividend payout ratio is currently 1,777.98%.

A number of research firms have recently commented on MET. Langen Mcalenn reissued a “buy” rating on shares of MetLife in a research report on Wednesday, August 16th. Wells Fargo & Company reissued a “buy” rating on shares of MetLife in a research report on Monday, August 7th. BidaskClub raised shares of MetLife from a “sell” rating to a “hold” rating in a research report on Wednesday, August 9th. Keefe, Bruyette & Woods reissued a “buy” rating and set a $59.00 target price on shares of MetLife in a research report on Thursday, August 3rd. Finally, Zacks Investment Research cut shares of MetLife from a “hold” rating to a “sell” rating in a research report on Wednesday, August 9th. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and ten have given a buy rating to the company’s stock. MetLife currently has a consensus rating of “Hold” and a consensus price target of $57.95.

COPYRIGHT VIOLATION NOTICE: “Mork Capital Management LLC Continues to Hold Position in MetLife, Inc. (MET)” was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another website, it was illegally stolen and republished in violation of US & international copyright and trademark law. The correct version of this story can be read at https://www.thecerbatgem.com/2017/09/17/mork-capital-management-llc-continues-to-hold-position-in-metlife-inc-met.html.

MetLife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Stock Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related stocks with our FREE daily email newsletter.